Among the PGC‐1 coactivator targets, the expression of estrogen‐related receptor alpha and its downstream genes decreased by up to 50%, while PPAR‐α and its downstream genes remained unchanged in heart failure patients. The gene discussed is PPARGC1B; the disease is heart failure.